SEC61A1

Chr 3AD

SEC61 translocon subunit alpha 1

Also known as: ADTKD5, CVID15, HNFJ4, HSEC61, SEC61, SEC61A

The protein encoded by this gene belongs to the SECY/SEC61- alpha family. It appears to play a crucial role in the insertion of secretory and membrane polypeptides into the endoplasmic reticulum. This protein found to be tightly associated with membrane-bound ribosomes, either directly or through adaptor proteins. This gene encodes an alpha subunit of the heteromeric SEC61 complex, which also contains beta and gamma subunits. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.293 OMIM phenotypes
Clinical SummarySEC61A1
🧬
Gene-Disease Validity (ClinGen)
SEC61A1 deficiency · ADModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.99). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
9 unique Pathogenic / Likely Pathogenic· 122 VUS of 363 total submissions
📖
GeneReview available — SEC61A1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.29LOEUF
pLI 0.987
Z-score 4.21
OE 0.11 (0.050.29)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
4.06Z-score
OE missense 0.32 (0.270.38)
92 obs / 284.9 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.11 (0.050.29)
00.351.4
Missense OE?0.32 (0.270.38)
00.61.4
Synonymous OE?1.04
01.21.6
LoF obs/exp: 3 / 26.3Missense obs/exp: 92 / 284.9Syn Z: -0.30
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedSEC61A1-related tubulo-interstitial and glomerulocystic kidney disease with anemiaOTHERAD

This gene — mechanism propensity

DN
0.6064th %ile
GOF
0.4974th %ile
LOF
0.56top 25%

The Badonyi & Marsh model scores dominant-negative highest, but genomic evidence most strongly supports loss-of-function (haploinsufficiency) as the primary mechanism.

LOF1 literature citation · LOEUF 0.29

Literature Evidence

LOFHeterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 27392076

ClinVar Variant Classifications

363 submitted variants in ClinVar

Classification Summary

Pathogenic5
Likely Pathogenic4
VUS122
Likely Benign180
Benign31
Conflicting5
5
Pathogenic
4
Likely Pathogenic
122
VUS
180
Likely Benign
31
Benign
5
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
4
0
0
5
Likely Pathogenic
0
4
0
0
4
VUS
4
101
14
3
122
Likely Benign
0
1
88
91
180
Benign
0
0
27
4
31
Conflicting
5
Total511012998347

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

12 pathogenic / likely-pathogenic (of 20) ClinVar copy-number / structural variants overlap SEC61A1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SEC61A1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →